Cowen Remains Bullish Following Workday (WDAY) Q1 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Canaccord Genuity Reiterate Buy Following Workday (WDAY) Q1
May 27, 2015 9:17 AM EDTCanaccord Genuity maintains a Buy rating on Workday (NYSE: WDAY), and cut the price target to $100.00 (from $110.00), following quarterly results. Analyst Richard Davis said that results showed upsides across the board. revenues of $251.0M, came in $6M ahead of estimates. Non-GAAP EPS beat estimates by $0.06.
Davis commented, saying, "We believe WDAY faces a decade of growth that... More
After-Hours Stock Movers 05/26: (EOX) (FPRX) (TIVO) Higher; (VNET) (WDAY) (COT) Lower (more...)
May 26, 2015 6:04 PM EDTEmerald Oil (NYSE: EOX) 53.6% HIGHER; elected not to proceed with its previously announced public offering of common stock. As a result of the Company's election not to proceed with its public offering, the Company will not be taking action to close the previously announced Delaware Basin acquisition.
Five Prime Therapeutics, Inc. (Nasdaq: FPRX) 20.2% HIGHER; bluebird bio (NASDAQ: BLUE) and Five Prime Therapeutics, Inc. (Nasdaq: FPRX) announced that they... More
Workday, Inc. (WDAY) Tops Q1 EPS by 6c, Offers Q2 Guidance
May 26, 2015 4:05 PM EDTWorkday, Inc. (NYSE: WDAY) reported Q1 EPS of ($0.02), $0.06 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $251 million versus the consensus estimate of $245.01 million.
Workday, Inc. sees Q2 2015 revenue of $270-274 million, versus the consensus of $272.39 million.
For... More
